Navigation Links
Phlo Affiliate Reports Progress in New York City Metropolitan Area Roll-Out

JACKSONVILLE, Fla., Feb. 11 /PRNewswire-FirstCall/ -- Further to Phlo Corporation's ("Phlo"") (OTC: PHLC) press release of December 27, 2007, "Phlo Affiliate Begins Roll Out to Metropolitan New York City Account Base," an affiliate of Phlo (the "Company") announced today that the Company's distributor in Metropolitan New York City has sold and delivered AQISS(TM) to the following initial retail accounts of its key account base as part of such roll out. AQISS(TM) is currently available for sale to the public in the retail accounts as follows:

-- New York Stock Exchange cafeteria

-- Morgan Stanley cafeteria

-- LA Sports Club

-- City Market

-- Crown Gourmet

-- Midtown Deli

-- Gold's Gym

-- Columbus Natural Food

-- Green Emporium

-- I&S

-- Hampton Deli

-- Westerly

-- Central Market

-- Village Gourmet Deli

-- West Side Market

-- Elm Health

-- Karrot Health Food Store

-- Organic Market

The Company will announce further sales and shipments to new retail accounts as progress occurs.

In addition, the Company will conduct a free public sampling of AQISS(TM) at Morgan Stanley (1 New York Plaza, New York, New York -- Broad Street south of Water Street) at noon on Wednesday, February 13, 2008. Morgan Stanley has purchased AQISS(TM) for sale in its cafeteria. The Company will conduct sampling programs at a number of accounts that have purchased AQISS(TM) for sale to the public. The Company will announce the location and date of some of these samplings as they are scheduled.

AQISS(TM) features the Company's Instant Nano Hydration and Cell Armor technologies, providing instant, direct delivery of rehydration and cell-repair-and-protection payloads into the bloodstream beginning through the membranes of the mouth. These Instant Nano Hydration and Cell Armor technologies help provide sustained wellness necessary for life's performances and vigorous longevity. In addition, the Company's nano-encapsulation technology prevents the destruction of its active payloads in the stomach.

Phlo is a biotechnology company and a manufacturer and marketer of products (primarily liquids) containing patented and patent-pending biotechnologies. Phlo is focusing its technology generation and acquisition efforts on those technologies related to enhancing cognition and personal performance, reducing the effects of aging, and preventing or ameliorating cancer.

Certain statements made herein that are not historical constitute "forward-looking" statements within the meaning of the Private Litigation Reform Act of 1995 and may contain words such as "anticipate," "believe," "expect," "future," "may," "will," "should," "plan," "projected," "intend," and similar expressions to identify such forward-looking statements. Such statements are based on a number of assumptions and on information and estimates supplied to Phlo Corporation by sources currently available to it. Such assumptions and estimates are subject to uncertainties, contingencies, and other factors, many of which are beyond Phlo Corporation's control. Actual results may differ materially from the statements set forth above.

SOURCE Phlo Corporation
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Bayer HealthCare Affiliate MEDRAD and Possis Medical Sign Definitive Merger Agreement
2. Phlo Affiliate Begins Roll Out to Metropolitan New York City Account Base
3. Phlo Affiliate Ships Product to Launch 450 7-Eleven Stores
4. Phlo Affiliate Names Director Of Marketing
5. Phlo Affiliate to Launch AQUISS(TM) on East Coast
6. Phlo Affiliate Hires Chief Marketing Officer With Extensive Global Experience
7. Phlo Affiliate Reports AQUISS to be Sold in 450 7-Eleven Stores
8. Phlo Affiliate Reports Expanded Coverage to Oregon Border
9. Cryo-Cell International, Inc. Reports Results for Fiscal 2007
10. Uroplasty Reports Record Sales for Third Fiscal Quarter and Nine Months Ended December 31, 2007
11. Bunge Reports Fourth Quarter Net Income of $245 Million
Post Your Comments:
(Date:6/23/2016)... June 23, 2016 A person commits a crime, ... scene to track the criminal down. An outbreak ... and Drug Administration (FDA) uses DNA evidence to track down ... Sound far-fetched? It,s not. The FDA has increasingly used ... investigations of foodborne illnesses. Put as simply as possible, whole ...
(Date:6/23/2016)... June 23, 2016  The Prostate Cancer Foundation (PCF) is pleased ... and faster cures for prostate cancer. Members of the Class of 2016 were ... Read More About the Class of 2016 PCF Young ... ... ...
(Date:6/23/2016)... ... June 23, 2016 , ... Supplyframe, ... of the Supplyframe Design Lab . Located in Pasadena, Calif., the Design ... of how hardware projects are designed, built and brought to market. , The ...
(Date:6/23/2016)... Ky. , June 23, 2016 ... two Phase 1 clinical trials of its complement ... placebo-controlled, single and multiple ascending dose studies designed ... pharmacodynamics (PD) of subcutaneous injection in healthy adult ... subcutaneously (SC) either as a single dose (ranging ...
Breaking Biology Technology:
(Date:5/12/2016)... 2016 , a brand of ... results from the Q1 wave of its quarterly wearables ... consumers, receptivity to a program where they would receive ... insurance company. "We were surprised to see ... Michael LaColla , CEO of Troubadour Research, "primarily because ...
(Date:4/28/2016)... 2016 First quarter 2016:   ... with the first quarter of 2015 The gross margin ... (loss: 18.8) and the operating margin was 40% (-13) ... Cash flow from operations was SEK 249.9 M (21.2) , ... unchanged, SEK 7,000-8,500 M. The operating margin for 2016 ...
(Date:4/15/2016)... , April 15, 2016  A new partnership ... more accurate underwriting decisions in a fraction of ... competitively priced and high-value life insurance policies to ... With Force Diagnostics, rapid testing (A1C, ... data readings (blood pressure, weight, pulse, BMI, and ...
Breaking Biology News(10 mins):